[Treatment of urogenital tuberculosis with ofloxacin. Preliminary study].
Ofloxacin is a new fluoride quinolone which has been shown to be active both in vitro and in vivo against Mycobacterium tuberculosis. This prospective study presents the results obtained with a new protocol for the treatment of genito-urinary tuberculosis. The comparison drugs were Ofloxacin 200 mg every 12 hours for 6 months, Rifampicin 600 mg every 24 for 3 months and Isoniazid 300 mg every 24 hours for 3 months. The results, were clinically and microbiologically good. It is concluded that this new drug should be a valid alternative to the traditional therapy.
Estebanez Zarranz
M J
MJ
Servicio de Urología, Hospital del Río Hortega, Valladolid.
Martínez-Sagarra
J M
JM
Alberte
A
A
Amón Sesmero
J
J
Rodríguez Toves
A
A
D000293:Adolescent; D000328:Adult; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015242:Ofloxacin / Q000627:therapeutic use*; D011446:Prospective Studies; D014401:Tuberculosis, Urogenital / Q000188:drug therapy*
D015242:Ofloxacin
Tratamiento de la tuberculosis génito-urinaria con ofloxacina. Estudio preliminar.